Week 11 and 12 Flashcards

(32 cards)

1
Q

Monoamine dopamine transmitters

A
  • Dopamine
  • Adrenaline (Epinephrine)
  • Noradrenaline (Norepinephrine)
  • Serotonin (5-hydroxytryptamine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which response system is noradrenaline associated with? and what does it do in the brain

A

ANS

o Arousal and mood (reward and pleasure from food, sex, drugs etc.)
o Regulation of BP in the brain stem
o Long term memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Main action of Serotonin (5-hydroxytryptamine)

A
  • Mood
  • Sexual
  • Sleep
  • Appetite
  • Pain
  • Motor function
  • Autonomic and endocrine functions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Therapeutic targeting of serotonin function

A
  • Antidepressants (SSRI’s and older drugs)
  • Antipsychotics (second generation i.e. The newer ones)
  • Antimigraine drugs
  • Anxiety
  • Obsessive-compulsive disorder
  • Alzheimer’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dopamine main functions

A
  • Very important in reward pathway and in behavioural drives
  • Initiation, planning and execution of movements
  • Control of prolactin release (inhibits it from the pituitary gland)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

4 pathways of dopamine from S. Nigra

A

o Nigrostriatal (control of movement)
o Mesocortical (forebrain, pleasures and planning/executive function)
o Mesolimbic (midbrain to deeper part of forebrain - limbic and motivational system)
o Tuberoinfundibular (projects down to the pituitary - controls release of prolactin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Therapeutic targeting of dopamine function

A
  • Psychosis
  • Parkinson’s Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Boosting Levels of Monoamines

A
  1. Monoamines (neurotransmitters) cross the synaptic cleft from the pre-synaptic neuron to attach to the receptors on the post-synaptic neuron. This stimulates a response.
  2. To end that signal (repolarisation), the neurotransmitters must be removed from the receptors to prevent continuous signalling. There are two ways this is done:
    a. Re-uptake using active pumps into the pre-synaptic cleft
    b. Enzymes that break down the neurotransmitters that are left hanging around in the synaptic cleft
    i. Monoamine Oxidase (MAO)
    ii. Catechol-o-methyl transferase (COMT)
    If you get a drug which inhibits any of these components, you’re going to raise the level of the monoamines in the synaptic cleft.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acetylcholine functions

A

Used as the communication between motor neurons and skeletal muscle allowing them to twitch
* Transmission at skeletal mm
* ANS - parasympathetic responses
* In the brain
o Short term memory
▪ People who suffer from dementia (particularly Alzheimer’s) suffer from degeneration of
ACh containing neurons in the hippocampus o Arousal and sleep
o Motivation and reward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Therapeutic targeting of ACH

A
  • Dementia
    o Treatment pharmacologically is new
    o Success with mild and recently diagnosed dementia
  • Parkinson’s
    o Use is falling - taking a backseat to the dopaminergic agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GABA Therapeutic uses

A

“Calming down”
* Inhibitory neurotransmitter
* Makes neuron less likely to respond to excitatory influences
Therapeutic targeting of GABA function
* Anticonvulsants
* Anxiolytics
o Anxiety disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glutamate therapeutic uses

A
  • Excitatory neurotransmitter
  • Excitotoxicity - over presence of glutamate causing death of cells post stroke/epilepsy Therapeutic targeting of Glutamate function
  • Stroke (neuroprotectives)
  • Anticonvulsants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs for treatment of anxiety

A

Anxiolytic Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Benzodiazepines uses and side effects

A
  • Most common form of treatment for anxiety
  • Act by binding to GABA-A receptor and increasing its activity
    o Side effect - sedating
  • Hypnotic (put your to sleep), sedative, mm relaxant, anticonvulsant (epilepsy, but not long term),
    amnesic (forget events)
  • Used for anxiety, insomnia, mm spasms, epilepsy, short endoscopic procedures, withdrawal from other
    CNS depressants e.g. Alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Benzodiazepines MOI

A
  • Binding site on this channel where the GABA binds (GABA-a receptor)
  • Opens chloride channel - chloride ions flow in to the cell from the outside (they are negatively charged)
    o Hyperpolarises the cell (negative on the inside) o Less likely to be depolarises
    o This is how GABA acts
  • Benzodiazepine works on the same channel and when bound, makes it more likely the channels will remain open for a longer period of time allowing more GABA to enter and stimulate more of a response
  • Alcohol works the same way
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does tolerance of benzodiazepines occur?

A

o Increased GABA influx - over the long term the GABA transmission levels have increased so the system responds to that by removing some of the receptors
▪ Increase dose of Benzodiazepine as a result - if you stop taking the drug, the capacity for GABA inhibition reduces meaning you have a dangerous low level of GABA inhibition resulting in an over-excitation of the CNS
▪ Can result in convulsions - withdrawal symptoms

17
Q

Buspirone (5HT and DA, not GABA benefits over typical anti-anxiety drugs

A

less sedation

18
Q

Main symptoms of depression

A
  • Misery, psychological pain
  • Pessimism
  • Low self-esteem
  • Guilt
  • Indecisiveness
  • Lack of motivation
  • Thought disorders
  • Depersonalisation
19
Q

other symptoms to depression

A
  • Autonomic symptoms: sweating, CV symptoms, headaches, tightness in chest, feeling of choking
  • Psychomotor retardation or acceleration (mental and physical functions)
  • Diurnal rhythm disturbance (sleep-wake cycles)
  • Insomnia, sometimes hypersomnia
  • Loss of libido
20
Q

two forms of depression

A

uni and bipolar

21
Q

symptoms of mania

A
  • Excessive euphoria
  • Excessive self-confidence
  • Pressure of speech
  • Impulsiveness
  • Grandiose ideas
  • Irritability
  • Impatience
  • Aggression
22
Q

Treatment of Unipolar Depression drugs

A

SSRI (most common), TCA’s , MAOI’s (least common)

23
Q

SSRIs: specific serotonin reuptake inhibitors (-oxetine) MOI

A

= reuptake inhibitor

24
Q

TCAs: tricyclics (-amine) MOi

A

= reuptake inhibitor
o Overdose possible

25
MAOIs: monoamine oxidase inhibitors. MOI
= blocking the breakdown of the neurotransmitters by blocking the enzyme o Block the activity of MAO-A and/or MAO-B o Some of the first drugs used to treat depression o Including ▪ Phenelzine, tranylcypromine, iproniazid = irreversible inhibitors To have active monoamine oxidase again, the body will have to make more ▪ Moclobermide = reversible, RIMA (reversible inhibitor of monoamine oxidase)
26
parkinsons symptoms
* Slow, reduced movements * Mask-like face * Trunk tilted forward * Reduced arm swinging * Tremors and rigidity * Shuffling gait with small steps * 'Pill rolling' tremor
27
L-Dopa side effects
o Nausea and vomiting o Hypotension o Arrhythmias o Dyskinesias o Nightmares o Confusion
28
main side effect of L-Dopa
Can readily get converted into dopamine, so dopamine related side effects
29
How to reduce side effects of L-dopa
o Prevent peripheral L-dopa metabolism by blocking the enzymes responsible o Then use lower doses of L-dopa o Incidence of common side effects 80% to 15% o What remain are the CNS effects (e.g. Confusion, nightmares etc.) o Effectiveness reduces over time -> on-off syndrome - shorter and shorter period of non-PD symptoms (it's a progressive disease) o Carbidopa - must be taken along with L-dopa ▪ Because these drugs cannot get through the blood-brain barrier, it only has an effect in the periphery which is what you want
30
-Dopamine agonists
Stimulate postsynaptic dopamine receptors Apomorphine, Carbegoline, Ropinirole
31
-MAO-B inhibitors
Block the breakdown of dopamine after it’s release from the nerve terminal, thus prolonging its action Selegiline, Rasagiline
32
MOA-B Inhibitors uses
MAO-B activity -> free radicals. Treatment which stimulates MAO-B activity = L-dopa -Block MAO-B also inc. dopamine